After COVID-related setbacks, placements of XACT Robotics Ltd.'s ACE hands-free robotic-assisted device for use in percutaneous interventional procedures are gaining traction in the US.
Harel Gadot, XACT’s founder and executive chairman, told Medtech Insight that the company expects to sell six ACE Robotic Systems by the end of June, adding to the four systems sold since it was first cleared by the US Food and Drug Administration in 2019